Williams Jones & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$8.53M Sell
106,615
-3,116
-3% -$239K 0.18% 84
2019
Q1
$8.71M Sell
109,731
-2,076
-2% -$155K 0.19% 82
2018
Q4
$8.15M Buy
111,807
+2,914
+3% +$206K 0.22% 82
2018
Q3
$7.37M Buy
108,893
+248
+0.2% +$15.8K 0.15% 105
2018
Q2
$6.29M Buy
108,645
+823
+0.8% +$46.4K 0.14% 107
2018
Q1
$5.6M Sell
107,822
-11,282
-9% -$609K 0.13% 113
2017
Q4
$6.39M Sell
119,104
-7,043
-6% -$390K 0.15% 111
2017
Q3
$7.71M Buy
126,147
+3,983
+3% +$241K 0.19% 99
2017
Q2
$7.47M Sell
122,164
-2,328
-2% -$142K 0.19% 97
2017
Q1
$7.55M Buy
124,492
+52
+0% +$3.15K 0.2% 104
2016
Q4
$6.99M Sell
124,440
-11,861
-9% -$694K 0.2% 103
2016
Q3
$8.12M Sell
136,301
-1,771
-1% -$104K 0.24% 92
2016
Q2
$7.59M Buy
138,072
+66,107
+92% +$3.52M 0.23% 91
2016
Q1
$3.63M Sell
71,965
-4,674
-6% -$229K 0.17% 95
2015
Q4
$3.86M Buy
76,639
+3,641
+5% +$184K 0.18% 99
2015
Q3
$3.44M Buy
72,998
+11,554
+19% +$614K 0.15% 114
2015
Q2
$3.34M Buy
61,444
+3,766
+7% +$211K 0.13% 129
2015
Q1
$3.16M Buy
57,678
+4,714
+9% +$267K 0.13% 133
2014
Q4
$2.87M Buy
52,964
+15,700
+42% +$875K 0.12% 135
2014
Q3
$2.11M Sell
37,264
-8,593
-19% -$483K 0.1% 131
2014
Q2
$2.53M Sell
45,857
-71,122
-61% -$3.88M 0.11% 117
2014
Q1
$6.34M Buy
116,979
+96,535
+472% +$5M 0.13% 124
2013
Q4
$976K Buy
20,444
+10
+0% +$457 0.05% 152
2013
Q3
$928K Sell
20,434
-7,972
-28% -$364K 0.05% 153
2013
Q2
$1.26M Buy
+28,406
New +$1.27M 0.06% 162

Other funds holding MRK

Williams Jones & Associates's MRK Position: Q2 2019 in Review

Williams Jones & Associates reduced its Merck (MRK) stake by 2.8% in Q2 2019, selling an estimated $239K and leaving 106,615 shares worth $8.53M. The position accounts for 0.18% of the portfolio, ranked #84.

Williams Jones & Associates first reported a position in MRK in Q2 2013 and has held it in 25 quarters since. The position peaked at $8.71M in Q1 2019. 2,299 funds tracked by Wall St. Rank hold MRK as of Q2 2019.

  • Williams Jones & Associates held 106,615 shares of Merck worth $8.53M as of Q2 2019.
  • Williams Jones & Associates sold 3,116 Merck shares in Q2 2019, an estimated $239K.
  • Merck made up 0.18% of Williams Jones & Associates's portfolio in Q2 2019, its #84 holding.
  • Williams Jones & Associates first reported a position in Merck in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Merck position peaked at $8.71M in Q1 2019.
  • 2,299 funds tracked by Wall St. Rank held Merck as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.